← Back to Search

Behavioral Intervention

STAR Program for Sepsis (ASTROS Trial)

N/A
Recruiting
Led By Marc A. Kowalkowski, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Organ dysfunction with two or more points on admission Sequential Organ Failure Assessment (SOFA) or two or more points on admission quick-SOFA
antibiotics initiated within 24 hours and continued for at least one additional day
Must not have
Reside > 2.5 hours drive time from the treating hospital
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights

Summary

This trial, called the ASTROS study, is testing the effectiveness of a program designed to improve outcomes for patients recovering from sepsis in new hospitals. The study will use a method called multiple interrupted

Who is the study for?
This trial is for adults over 18 with suspected infection and signs of systemic inflammation, who've started antibiotics within 24 hours that continued for at least another day. They must have organ dysfunction indicated by SOFA scores or be at high risk of hospital readmission within 90 days.
What is being tested?
The ASTROS study is testing the STAR Program against usual care to see if it improves recovery after sepsis in new hospital settings. It uses a multiple interrupted time series analysis to measure effectiveness as hospitals adopt the program.
What are the potential side effects?
Since this trial compares standard post-sepsis care with the STAR Program, side effects are not drug-related but may include potential risks associated with changes in healthcare delivery methods.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My organs are not functioning well according to a recent assessment.
Select...
I started antibiotics within a day and took them for at least another day.
Select...
I started antibiotics within a day of showing infection signs and continued for at least another day.
Select...
I might have an infection based on my symptoms.
Select...
I am currently hospitalized.
Select...
I am currently hospitalized.
Select...
My organs are not working properly.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I live more than 2.5 hours away from the hospital by car.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
All-cause mortality and hospital readmission rate
Secondary study objectives
Acute care-related costs
All-cause hospital readmission rate
All-cause mortality rate
+1 more
Other study objectives
Number of eligible patients reached by STAR program
Number of providers included in STAR program adoption
Proportion of patients with STAR program intervention delivered as intended
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Sepsis Transition and Recovery (STAR) programExperimental Treatment1 Intervention
Virtual sepsis navigation delivered across the peri-hospital discharge interval
Group II: Usual CareActive Control1 Intervention
Standard of care received through each facility for patients hospitalized with sepsis. Aspects of usual care will be determined by treating clinicians independent of trial assignment.

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,266 Previous Clinical Trials
1,012,427 Total Patients Enrolled
8 Trials studying Sepsis
5,012 Patients Enrolled for Sepsis
The Duke EndowmentOTHER
13 Previous Clinical Trials
38,872 Total Patients Enrolled
Marc A. Kowalkowski, PhDPrincipal InvestigatorWake Forest University Health Sciences
~741 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top